Overview

Myocardial Protection and Anesthetic Agents

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to investigate the myocardial protective effects of remifentanil and dexmedetomidine in cardiac surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Cukurova University
Treatments:
Dexmedetomidine
Remifentanil
Sevoflurane